Associations of Macro- and Microvascular Endothelial Dysfunction with Subclinical Ventricular Dysfunction in End-Stage Renal Disease

Ruth F. Dubin*, Isabella Guajardo, Amrita Ayer, Claire Mills, Catherine Donovan, Lauren Beussink, Rebecca Scherzer, Peter Ganz, Sanjiv J. Shah

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Patients with end-stage renal disease (ESRD) suffer high rates of heart failure and cardiovascular mortality, and we lack a thorough understanding of what, if any, modifiable factors contribute to cardiac dysfunction in these high-risk patients. To evaluate endothelial function as a potentially modifiable cause of cardiac dysfunction in ESRD, we investigated cross-sectional associations of macro- and microvascular dysfunction with left and right ventricular dysfunction in a well-controlled ESRD cohort. We performed comprehensive echocardiography, including tissue Doppler imaging and speckle-tracking echocardiography of the left and right ventricle, in 149 ESRD patients enrolled in an ongoing prospective, observational study. Of these participants, 123 also underwent endothelium-dependent flow-mediated dilation of the brachial artery (macrovascular function). Microvascular function was measured as the velocity time integral of hyperemic blood flow after cuff deflation. Impaired flow-mediated dilation was associated with higher left ventricular mass, independently of age and blood pressure: per 2-fold lower flow-mediated dilation, left ventricular mass was 4.1% higher (95% confidence interval, 0.49-7.7; P=0.03). After adjustment for demographics, blood pressure, comorbidities, and medications, a 2-fold lower velocity time integral was associated with 9.5% higher E/e′ ratio (95% confidence interval, 1.0-16; P=0.03) and 6.7% lower absolute right ventricular longitudinal strain (95% confidence interval, 2.0-12; P=0.003). Endothelial dysfunction is a major correlate of cardiac dysfunction in ESRD, particularly diastolic and right ventricular dysfunction, in patients whose volume status is well controlled. Future investigations are needed to determine whether therapies targeting the vascular endothelium could improve cardiac outcomes in ESRD.

Original languageEnglish (US)
Pages (from-to)913-920
Number of pages8
Issue number4
StatePublished - Oct 1 2016


  • cardiovascular disease
  • echocardiography
  • heart failure

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Associations of Macro- and Microvascular Endothelial Dysfunction with Subclinical Ventricular Dysfunction in End-Stage Renal Disease'. Together they form a unique fingerprint.

Cite this